Skip to Content

Zolbetuximab (Vyloy®) for Gastroesophageal Cancers

Download PQI pdf 0.26MB

Last Updated: May 19, 2025

By: Dr. Reetu Mukherji, MD

About this PQI

This PQI will discuss clinical information regarding zolbetuximab in the management of patients with gastroesophageal cancers and to provide insights into best clinical practices.

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care. Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Find a PQI